Lipton H L, Calenoff M, Bandyopadhyay P, Miller S D, Dal Canto M C, Gerety S, Jensen K
Department of Neurology, University of Colorado Health Sciences Center, Denver 80262.
J Virol. 1991 Aug;65(8):4370-7. doi: 10.1128/JVI.65.8.4370-4377.1991.
RNA transcripts derived from recombinant chimeras between the highly virulent GDVII virus and the less virulent BeAn virus were constructed to study the molecular pathogenesis of Theiler's murine encephalomyelitis virus infection. The presence of the BeAn 5' noncoding sequences in chimera 2 (BeAn 5' noncoding sequences joined with the GDVII nucleotides encoding the polyprotein and present in the 3' end) resulted in dramatic attenuation of GDVII neurovirulence and development of poliomyelitis in mice. This reduced neurovirulence was associated with slower virus growth and lower peak titers in the brain and spinal cord than with parental GDVII virus replication. On the other hand, the sites of replication following chimera 2 infection were the same as those seen in GDVII-infected mice; the distribution of virus antigen and histopathological changes indicated that chimera 2 replicates in neurons in the brain, e.g., in the neocortex, hippocampus, caudate putamen, and brain stem, as well as in anterior-horn cells in the spinal cord. Chimera 2 was efficiently cleared from the mouse central nervous system by day 30 postinfection, in marked contrast to the persistence of the BeAn parent in the central nervous system. This suggests that elements in the BeAn sequences that encode the polyprotein or are present in the 3' noncoding region are necessary for viral persistence. It is of interest that chimera 2-infected mice developed localized inflammatory, demyelinating lesions which were detected at day 28 postinfection but these lesions did not become larger with time. Thus, virus persistence appears to be required for maintenance and progression of immune-mediated demyelination. If the demyelinating lesions become sufficiently large, clinical signs and disease may develop.
构建了高毒力GDVII病毒与低毒力BeAn病毒之间重组嵌合体的RNA转录本,以研究泰勒氏鼠脑脊髓炎病毒感染的分子发病机制。嵌合体2中存在BeAn 5'非编码序列(BeAn 5'非编码序列与编码多蛋白的GDVII核苷酸相连并存在于3'末端)导致GDVII神经毒力显著减弱,且小鼠发生脊髓灰质炎。这种降低的神经毒力与病毒生长较慢以及与亲本GDVII病毒复制相比脑和脊髓中的峰值滴度较低有关。另一方面,嵌合体2感染后的复制位点与GDVII感染小鼠中的相同;病毒抗原的分布和组织病理学变化表明嵌合体2在脑中的神经元中复制,例如在新皮层、海马体、尾状壳核和脑干中,以及脊髓的前角细胞中。感染后30天,嵌合体2从小鼠中枢神经系统中有效清除,这与BeAn亲本在中枢神经系统中的持续存在形成鲜明对比。这表明编码多蛋白或存在于3'非编码区的BeAn序列中的元件是病毒持续存在所必需的。有趣的是,嵌合体2感染的小鼠出现了局部炎症性脱髓鞘病变,在感染后第28天被检测到,但这些病变并未随时间变大。因此,病毒持续存在似乎是免疫介导的脱髓鞘维持和进展所必需的。如果脱髓鞘病变变得足够大,可能会出现临床症状和疾病。